Creso Pharma Limited [ASX:CPH] share price and news 2022

Company Description

Creso Pharma Limited (CPH) is a leader in cannabidiol (CBD) innovation, developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. They bring pharmaceutical expertise and methodological rigor to the cannabis world and strives for the quality in their products. The Group is developing products in four key categories and operates in Europe, North America, Latin America and Oceania.

Creso Pharma Limited belongs to Health Care sector and under industry of Pharmaceuticals. You can get more information about this company via their website: http://www.cresopharma.com.

This a small cap company with market cap of 200 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 13.9 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how cph dividend grows in the recent years.

No data